Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2002
11/21/2002US20020173498 Topical administering; skin disorders
11/21/2002US20020173497 Stability; oral administering; anticancer agents
11/21/2002US20020173496 Formulation containing novel anti-inflammatory androstane derivative
11/21/2002US20020173487 Cyclodextrin-drospirenone inclusion complexes
11/21/2002US20020173485 Mixture of hyaluronic acid and polyvinylpyrrolidone
11/21/2002US20020173474 Methods & materials involving dimerization-mediated regulation of biological events
11/21/2002US20020173472 Pharmaceutical formulations of resveratrol
11/21/2002US20020173467 Peptide in biopolymer; oil in water emulsion
11/21/2002US20020173456 Complex of macromolecules and peptide; supplying cells
11/21/2002US20020173451 Using mixture of prostate specific antigen and radiation therapy
11/21/2002US20020172942 Composition for use in the treatment and prevention of viral infections
11/21/2002US20020172933 Protected during pasteurization stabilizers (monosaccharides, disaccharides, and oligosaccharides; or amino acids)
11/21/2002US20020172727 Multiparticulate formulations of lithium salts for oral administration suitable for once-a-day administration
11/21/2002US20020172721 Vitamin formulation for cardiovascular health
11/21/2002US20020172712 Antiemetic, anti-motion sustained release drug delivery system
11/21/2002US20020172680 Diagnosis of metastatic cancer by the mts-1 gene
11/21/2002US20020172670 Used to generate models for elucidating the structure of other polypeptides and for better identifying ligands capable of modulating mannosidase II activity
11/21/2002US20020172661 For diagnosis, prevention, or treatment of diseases responsive to therapy with interferon- beta (IFN-beata)
11/21/2002US20020172649 Pharmaceutical composition
11/21/2002CA2826627A1 Specific binding proteins and uses thereof
11/21/2002CA2778114A1 Abuse-resistant opioid dosage form
11/21/2002CA2448195A1 Minoxidil-containing liquid composition
11/21/2002CA2447574A1 Oxidized collagen formulations for use with non-compatible pharmaceutical agents
11/21/2002CA2447548A1 Complexes for transferring substances of interest into a cell
11/21/2002CA2447444A1 Antisense permeation enhancers
11/21/2002CA2447395A1 Targeted delivery of drugs for the treatment of parasitic infections
11/21/2002CA2447287A1 Immunoconjugates made of egg-yolk antibodies (igy), production and use thereof in diagnoses and therapy
11/21/2002CA2447275A1 Therapeutic delivery of carbon monoxide
11/21/2002CA2447005A1 Oral controlled release pharmaceutical composition for one-a-day therapy for the treatment and prophylaxis of cardiac and circulatory diseases
11/21/2002CA2446957A1 Compaction process for manufacture of sodium phenytoin dosage form
11/21/2002CA2446751A1 Kavalactone compositions and methods of use
11/21/2002CA2446589A1 Methods for treating cancer
11/21/2002CA2446555A1 Immunogenic conjugates of low molecular weight hyaluronic acid with polypeptide toxins
11/21/2002CA2446106A1 System for delivering cosmetics and pharmaceuticals
11/21/2002CA2445606A1 Taste masking pharmaceutical composition
11/20/2002WO2001091755A1 Active substance combination containing a compound with an opioid effect and at least one further compound of formula i
11/20/2002WO2001090252A1 Gelling composition
11/20/2002EP1258775A2 Photothermographic materials and recording processes therefor
11/20/2002EP1258522A2 A method of controlling the oxidation of chemicals during storage using noble gases
11/20/2002EP1258497A2 Conjugates of factor VIII and a biocompatible polymer
11/20/2002EP1258255A1 Conjugates of an antibody to CD44 and a maytansinoid
11/20/2002EP1258249A1 Oral preparations for diabetes
11/20/2002EP1258246A2 Controlled release oxycodone compositions
11/20/2002EP1258245A2 Accelerated release composition containing bromocriptine
11/20/2002EP1258241A1 Method of increasing the bioavailability of nimesulide
11/20/2002EP1258200A2 Use of hydroxyflavones for masking of bitterness, and food and pharmaceutical compositions comprising an effective amount thereof
11/20/2002EP1257827A1 Diagnosis of breast cancer using bcmp-11 as marker
11/20/2002EP1257695A1 Biomolecules having multiple attachment moieties for binding to a substrate surface
11/20/2002EP1257654A1 M cell directed vaccines
11/20/2002EP1257574A1 Improved interleukin 10
11/20/2002EP1257304A1 Foam-forming wound dressing
11/20/2002EP1257299A2 Radioactive therapeutic liposomes
11/20/2002EP1257297A2 Compositions and methods for treatment of angiogenesis in pathological lesions
11/20/2002EP1257296A2 Caspase activated prodrugs therapy
11/20/2002EP1257295A2 Factor vii or viia-like molecules
11/20/2002EP1257291A1 Novel antibody with specificity for colon cancer
11/20/2002EP1257285A2 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer
11/20/2002EP1257269A1 Orally administrable acid stable anti-ulcer benzimidazole derivatives
11/20/2002EP1257259A1 Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
11/20/2002EP1257257A2 Delivery systems using preformed biodegradable polymer compositions and methods
11/20/2002EP1257248A1 Pharmaceutical composition
11/20/2002EP1107732B1 Oral liquid mucoadhesive compositions
11/20/2002EP1054666B1 Liquid pharmaceutical formulation containing zotepine
11/20/2002EP1052995B1 Pharmaceutical composition for nasal administration of thiocolchicoside
11/20/2002EP1003525B1 Composition and method for regulating cell proliferation and cell death
11/20/2002EP0954337B1 Intestinal absorption of nicotine to treat nicotine responsive conditions
11/20/2002EP0929314B1 Pharmaceutical formulations of corticotropin releasing factor having improved stability in liquid form
11/20/2002EP0879050B1 Captopril tablets
11/20/2002EP0868174B1 Oral gel capsule formulation of 1,2,4-benzotriazine oxides
11/20/2002EP0847280B1 Compositions and their uses against hyperacute rejection of xenografts and certain diseases
11/20/2002EP0711127B1 Methods of preparing gas-filled liposomes
11/20/2002EP0695169B1 Multivesicular cyclodextrin liposomes encapsulating pharmacologic compounds and methods for their use
11/20/2002EP0681481B1 Highly soluble multicomponent inclusion complexes containing a base type drug, an acid and a cyclodextrin
11/20/2002CN1380830A Patch containing 4-biphenylacetic acid
11/20/2002CN1380829A Rapidly disintegrating table and process for manufacture thereof
11/20/2002CN1380064A Method for producing antibiotic preparation and its application
11/20/2002CN1094361C Composition comprising propolis and essential oil
11/20/2002CN1094351C External-use medicine 'Gujiasan' powder and its preparing method
11/20/2002CN1094350C Preparation for epidermis and process for its preparation
11/20/2002CN1094349C Pharmaceutical composition
11/20/2002CN1094326C Carotenoid preparation having mixture of beta-carotene, ycopene and xanthophyll
11/20/2002CA2410038A1 Gelling composition
11/19/2002US6482987 Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
11/19/2002US6482943 Quinones as disease therapies
11/19/2002US6482917 Method for producing powder-shaped cross-linked polymerizates
11/19/2002US6482823 Taste masked pharmaceutical liquid formulations
11/19/2002US6482811 Bretylium compositions and kits, and their use in preventing and treating cardio-vascular conditions
11/19/2002US6482586 Hybrid compositions for intracellular targeting
11/19/2002US6482518 Excipient for the lyophilization of aqueous suspensions of microparticles
11/19/2002US6482517 Coated particles, methods of making and using
11/19/2002US6482439 Drug delivery system exhibiting permeability control
11/19/2002US6482438 Apparatus and process for preparing crystalline particles
11/19/2002US6482437 Morphine sulfate microgranules, manufacturing process and pharmaceutical preparations
11/19/2002US6482435 Temperature sensitive gel for sustained delivery of protein drugs
11/19/2002US6482433 Instant foods, beverages
11/19/2002US6482431 Method for application and maintenance of medication on body tissue
11/19/2002US6482430 Improvements Relating To Bran Gels
11/19/2002US6482429 Stable powder inhalation dosage formulation
11/19/2002US6482426 Compositions for the treatment of male erectile dysfunction
11/19/2002US6482421 Pharmaceuticals, dietary supplements and cosmetic compositions, and the use of certain mixtures for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation, hypersensitivity reactions or pain